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ABSTRACT 
Primary epiploic appendagitis (PEA) is an uncommon and self-limiting cause of acute or subacute abdominal 
complaints. The diagnosis of PEA, with its characteristic appearance, is made with computed tomography (CT). 
This report describes a patient seven months after a CT-confirmed diagnosis of PEA. Because of persistent and 
recurring, functional, non-specific abdominal complaints, food intolerance/malabsorption was investigated. Fruc-
tose malabsorption combined with histamine intolerance was found. A registered dietician helped develop an in-
dividually-tailored diet to address the problem. Within four days of beginning the fructose-free and histamine-
reduced diet, the patient’s complaints resolved. In conclusion, abdominal symptoms caused by fructose malab-
sorption and histamine intolerance may have been triggered by PEA in this patient.  
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INTRODUCTION 
Primary epiploic appendagitis (PEA) is a 
rare, benign, self-limiting inflammation of 
epiploic appendages, which are adipose struc-
tures protruding from the colon. The use of 
cross-sectional imaging computed tomogra-
phy (CT) for the primary evaluation of ab-
dominal pain has increased the recognition of 
PEA over the past years. The pain in PEA is 
reported as being dull, constant and non-mi-
grating (Schnedl et al., 2011). Adverse reac-
tions to ingested food are a result of the intol-
erance/malabsorption of carbohydrates (lac-
tose and fructose), proteins (gluten), and bio-
genic amines (histamine). In food intoler-
ance/malabsorption, one or more food ingre-
dients cannot be digested and/or absorbed 
properly within the gastrointestinal tract 
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(Enko et al., 2016). Symptoms include persis-
tent and recurring, functional, non-specific 
abdominal complaints, such as: bloating, 
semisolid stools, intermittent diarrhea and mi-
grating abdominal pain. This report describes 
a patient who seven months earlier had been 
diagnosed with PEA using CT. Due to ab-
dominal complaints, we investigated food in-
tolerance/malabsorption. Fructose malab-
sorption combined with histamine intolerance 
was diagnosed. An individually-tailored fruc-
tose-free and histamine-reduced diet resolved 
the patient’s symptoms. 
 
CASE REPORT 
A 48-year-old white male patient pre-
sented with persistent and recurring, func-
tional, non-specific abdominal complaints, 
including bloating, semisolid stools and inter-
mittent diarrhea up to a maximum of three 
times per day. Physical examination revealed 
a bloated abdomen and migrating, non-local-
ized pain and tenderness. Abdominal sonog-
raphy showed gas distention, but no other ab-
normalities. Anamnesis revealed that he had 
had a CT-diagnosed epiploic appendagitis 
seven months prior (Figure 1). The patient 
was concerned about the continuing PEA be-
cause he experienced persistent and recurring 
abdominal symptoms after the initial diagno-
sis. Through anamnesis the symptoms were 
correlated with the ingestion of food of 
drinks. Consequently, food malabsorption/in-
tolerance was suspected. 
We used hydrogen (H2) breath tests (Gas-
trolyzer, Bedfont Scientific Inc., Kent, Eng-
land) for the evaluation of lactose intolerance 
and fructose malabsorption. During a hydro-
gen breath test with a drink containing 25 g of 
fructose, the exhalation demonstrated increas-
ing H2 values of up to 86 parts per million 
(normal < 20) and the diagnosis of fructose 
malabsorption was confirmed. Diamine oxi-
dase (DAO) in the serum was measured with 
the radio extraction assay DAO Rea 100 (Sci-
otec Diagnostic Technologies, Tulln, Austria) 
and was determined to be 3 U/mL (normal 
> 10). This DAO value, combined with ab-
dominal complaints and the correlation with 
the ingestion of histamine-containing food, 
indicated histamine intolerance. The lactose 
breath test with a 50 g lactose load showed no 
increase in exhaled H2 and simultaneously 
measured blood glucose increased by 
> 20 mg/dl. An enzyme-linked IgA immuno-
sorbent assay (ELISA, Serion, Würzburg, 
Germany) showed the absence of Helicobac-
ter pylori infection. In the screening for celiac 
disease, antibodies against tissue transglutam-
inase with anti-tTG IgA ELISA (Euro Diag-
nostica AB, Malmö, Sweden) were not found. 
A CT of the abdomen performed as follow up 
to the PEA diagnosed 7 months prior demon-
strated no anomalies. Triglycerides were 
228 mg/dl (normal < 150), but all of the other 
routine laboratory parameters, including 
erythrocyte sedimentation rate and liver and 
pancreas enzymes, were within normal limits. 
A colonoscopy also showed no abnormalities. 
 
 
Figure 1: Contrast enhanced axial abdominal CT 
demonstrating primary epiploic appendagitis adja-
cent to the sigmoid colon 7 months prior to 
presentation 
 
Seven months earlier, an abdominal CT 
with intravenous contrast medium demon-
strated an oval lesion with a maximum diam-
eter of 1.7 x 0.7 cm located at the sigmoid co-
lon. The diagnosis of PEA was arrived at 
based on the hyperattenuated rim, surrounded 
by fat stranding, which indicated an inflamed 
and thickened visceral peritoneum surround-
ing the fat-containing appendage (Figure 2). 
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Figure 2: Longitudinal abdominal CT with con-
trast enhancement demonstrating primary 
epiploic appendagitis adjacent to the sigmoid co-
lon 7 months prior to presentation 
 
 
With the diagnosis of combined food in-
tolerance/malabsorption, the patient received 
written information on fructose malabsorp-
tion and histamine intolerance. A registered 
dietician helped develop an individually-tai-
lored diet to address the symptomatology and 
to ensure nutritional adequacy. Within 4 days 
of beginning the fructose-free and histamine-
reduced diet, the patient’s complaints re-
solved. Written informed consent was ob-
tained for all procedures, which were in ac-
cordance with the Declaration of Helsinki and 
the recommendations of the local ethics com-
mittee. 
 
DISCUSSION 
Appendices epiploicae are 50 to 100 sub-
serosal fat pouches lining the entire length of 
the colon. They are attached to the colon wall 
with a vascular stalk and appear in two rows 
along the tenias. There is only one row along 
the transverse colon. This explains why cases 
of PEA are predominantly reported at the sig-
moid and ascending colon. Clinically, PEA is 
accompanied by localized pain mainly in the 
lower left or right abdominal quadrant. This 
pain is described as dull, constant and non-mi-
grating. Physical examination may show a 
well-localized tenderness (Schnedl et al., 
2011). However, the pain in PEA can be sim-
ilarly identified as diverticulitis, cholecystitis 
or appendicitis (Singh et al., 2005) because 
clinicians are frequently unfamiliar with PEA 
(Almeida et al., 2009). It usually resolves 
within a few days to a few weeks without 
medical or surgical treatment. 
CT is the diagnostic modality of choice 
for identifying PEA with its characteristic and 
diagnostic appearance (Rioux and Langis, 
1994). The use of CT scans for the primary 
evaluation of acute and subacute abdominal 
pain is increasing, but, so far, only about 200 
publications on PEA exist. PEA is assumed to 
be a localized sterile inflammation in and ad-
jacent to a distorted epiploic appendage. This 
torsion may lead to ischemia, infarction, asep-
tic fat necrosis, and spontaneous venous 
thrombosis (Ozdemir et al., 2010). Regular 
non-tortured epiploic appendages cannot be 
seen on CT scans. A secondary epiploic ap-
pendagitis can develop along with the inflam-
mation of neighboring organs, such as chole-
cystitis, pancreatitis, diverticulitis, or appen-
dicitis (Lorente et al., 2017).  
Usually bowel habits are not disturbed by 
PEA, although a few reports described post-
prandial fullness, bloating, constipation, diar-
rhea and vomiting (Schnedl et al., 2014). In 
this patient we documented the difference be-
tween the symptoms from PEA and food in-
tolerance/malabsorption. Seven months of a 
bloated abdomen, semisolid stools and the 
migrating, non-localized pain were found to 
be caused by fructose malabsorption and his-
tamine intolerance. 
In fructose malabsorption, this monosac-
charide is not adequately absorbed by the ep-
ithelial glucose transporters, mainly GLUT-5, 
in the intestinal mucosa. Fructose reaches the 
large intestine where it serves as a bacterial 
substrate. This results in fermentation with 
hydrogen production (Gibson et al., 2007). 
Within the gastrointestinal tract, the enzyme 
diamine oxidase (DAO) appears to be central 
to the degradation of ingested histamine. Ab-
dominal complaints in histamine intolerance 
(HIT) result mainly from the consumption of 
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histamine-containing food and the reduced 
ability of DAO to digest histamine. Serum 
DAO values may be used for the diagnosis of 
HIT (Mušič et al., 2013), but there is no es-
tablished correlation with gastrointestinal 
DAO activity (Reese et al., 2017). Various 
combinations of intolerance/malabsorption, 
as in this patient, have been proposed to cause 
persistent and recurring, functional, non-spe-
cific abdominal symptoms (Enko et al., 
2016). 
 
CONCLUSION 
Numerous mechanisms – visceral hyper-
sensitivity, irregular gut motility, abnormal 
brain-gut interactions, and infectious agents – 
are thought to be related to the initiation and 
development of functional, non-specific ab-
dominal symptoms (Shariati et al., 2019). In 
conclusion, abdominal complaints caused by 
concomitant fructose malabsorption and his-
tamine intolerance may have been triggered 
by PEA in this patient.  
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